Beacon Investment Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$472K	Sell	757 -9,055	-92%	-$6.16M	0.02%	189
2026 Q1	$7.58M	Sell	9,812 -263	-3%	-$201K	0.31%	78
2025 Q4	$7.78M	Sell	10,075 -1,450	-13%	-$985K	0.32%	73
2025 Q3	$6.48M	Sell	11,525 -11,990	-51%	-$6.78M	0.27%	85
2025 Q2	$12.3M	Sell	23,515 -2,744	-10%	-$1.53M	0.54%	52
2025 Q1	$16.7M	Buy	26,259 +1,751	+7%	+$1.2M	0.78%	45
2024 Q4	$17.5M	Sell	24,508 -2,678	-10%	-$2.25M	0.76%	49
2024 Q3	$28.6M	Buy	27,186 +198	+0.7%	+$220K	1.19%	28
2024 Q2	$28.4M	Buy	26,988 +592	+2%	+$574K	1.22%	27
2024 Q1	$25.4M	Buy	26,396 +407	+2%	+$387K	1.1%	30
2023 Q4	$22.8M	Buy	25,989 +7,523	+41%	+$6.2M	1.04%	31
2023 Q3	$15.2M	Buy	18,466 +9,225	+100%	+$7.25M	0.75%	44
2023 Q2	$6.64M	Buy	9,241 +566	+7%	+$436K	0.31%	75
2023 Q1	$7.13M	Buy	8,675 +54	+0.6%	+$40.7K	0.35%	67
2022 Q4	$6.22M	Buy	+8,621	New	+$6.36M	0.32%	71
2020 Q3	–	Sell	-325	Closed	-$203K	–	263
2020 Q2	$203K	Buy	+325	New	+$184K	0.01%	233
2019 Q2	–	Sell	-519	Closed	-$213K	–	235
2019 Q1	$213K	Buy	+519	New	+$214K	0.02%	215
2018 Q4	–	Sell	-844	Closed	-$341K	–	262
2018 Q3	$341K	Sell	844 -6	-0.7%	-$2.28K	0.03%	206
2018 Q2	$293K	Buy	850 +3	+0.4%	+$938	0.03%	215
2018 Q1	$292K	Buy	847 +30	+4%	+$10.4K	0.03%	220
2017 Q4	$307K	Sell	817 -167	-17%	-$67.6K	0.03%	201
2017 Q3	$440K	Buy	+984	New	+$468K	0.04%	190